Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 3
1997 10
1998 25
1999 22
2000 24
2001 23
2002 36
2003 52
2004 57
2005 57
2006 94
2007 72
2008 70
2009 63
2010 57
2011 55
2012 60
2013 51
2014 45
2015 44
2016 53
2017 45
2018 57
2019 43
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

1,030 results
Results by year
Filters applied: . Clear all
Page 1
Lamotrigine Rechallenge in Treatment-Resistant Bipolar Disorder.
Inaba T, Sogawa R, Mizoguchi Y, Tateishi H, Kunitake Y, Kato TA, Monji A. Inaba T, et al. Prim Care Companion CNS Disord. 2018 Mar 29;20(2):17m02231. doi: 10.4088/PCC.17m02231. Prim Care Companion CNS Disord. 2018. PMID: 29659202 Free article.
METHODS: We investigated lamotrigine rechallenge for the treatment of bipolar disorder. The present study was based on retrospective chart review of outpatients with bipolar disorder (DSM-5 criteria) who visited the hospital's psychiatric department be …
METHODS: We investigated lamotrigine rechallenge for the treatment of bipolar disorder. The present study was based on retrosp …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. While medications that have been shown to be effective for the acute phase should generally be …
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, l …
Treatment of Peripartum Bipolar Disorder.
Clark CT, Wisner KL. Clark CT, et al. Obstet Gynecol Clin North Am. 2018 Sep;45(3):403-417. doi: 10.1016/j.ogc.2018.05.002. Obstet Gynecol Clin North Am. 2018. PMID: 30092918 Free PMC article. Review.
Bipolar disorder affects women throughout their childbearing years. During the perinatal period, women with bipolar disorder are vulnerable to depressive episode recurrences and have an increased risk for postpartum psychosis. ...Residual symptoms of bipolar
Bipolar disorder affects women throughout their childbearing years. During the perinatal period, women with bipolar disorder a
Preventive Effects of Lamotrigine in Bipolar II Versus Bipolar I Disorder.
Terao T, Ishida A, Kimura T, Yarita M, Hara T. Terao T, et al. J Clin Psychiatry. 2017 Sep/Oct;78(8):e1000-e1005. doi: 10.4088/JCP.16m11404. J Clin Psychiatry. 2017. PMID: 28817765 Free article.
OBJECTIVE: The preventive effects of mood stabilizers on recurrence/relapse in bipolar disorders have been investigated mostly in bipolar I disorder (BPI) patients, with limited reports on bipolar II disorder (BPII) patients. ...CONCLUSIONS: Although the prev …
OBJECTIVE: The preventive effects of mood stabilizers on recurrence/relapse in bipolar disorders have been investigated mostly in …
Melancholic Symptoms in Bipolar II Depression and Responsiveness to Lamotrigine in an Exploratory Pilot Study.
Peters EM, Bowen R, Balbuena L. Peters EM, et al. J Clin Psychopharmacol. 2018 Oct;38(5):509-512. doi: 10.1097/JCP.0000000000000947. J Clin Psychopharmacol. 2018. PMID: 30124585 Clinical Trial.
METHODS: Adult outpatients (n = 150) in an acute bipolar II depressive episode completed 8 weeks of treatment with lamotrigine (titrated to 200 mg/d) or placebo. ...CONCLUSIONS: Further research is warranted to test the hypothesis that bipolar depression with …
METHODS: Adult outpatients (n = 150) in an acute bipolar II depressive episode completed 8 weeks of treatment with lamotrigine
Lamotrigine Uses in Psychiatric Practice.
Naguy A, Al-Enezi N. Naguy A, et al. Am J Ther. 2019 Jan/Feb;26(1):e96-e102. doi: 10.1097/MJT.0000000000000535. Am J Ther. 2019. PMID: 30601211 Review.
BACKGROUND: Lamotrigine (LAM), an antiepileptic, with panoply of indications and uses in neurology, is FDA approved, in psychiatry, for bipolar prophylaxis. ...RESULTS: Sound evidence supports use of LAM for acute bipolar depression and prophylaxis, treatment …
BACKGROUND: Lamotrigine (LAM), an antiepileptic, with panoply of indications and uses in neurology, is FDA approved, in psychiatry, f …
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. Solmi M, et al. CNS Spectr. 2016 Oct;21(5):403-418. doi: 10.1017/S1092852916000523. CNS Spectr. 2016. PMID: 27686028
OBJECTIVES: To meta-analytically summarize lamotrigine's effectiveness and safety in unipolar and bipolar depression. METHODS: We conducted systematic PubMed and SCOPUS reviews (last search =10/01/2015) of randomized controlled trials comparing lamotrigine
OBJECTIVES: To meta-analytically summarize lamotrigine's effectiveness and safety in unipolar and bipolar depression. M …
Lamotrigine for people with borderline personality disorder: a RCT.
Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson VC, Lemonsky F, Lykomitrou-Matthews G, Montgomery A, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG. Crawford MJ, et al. Health Technol Assess. 2018 Apr;22(17):1-68. doi: 10.3310/hta22170. Health Technol Assess. 2018. PMID: 29651981 Free PMC article. Clinical Trial.
OBJECTIVE: To examine the clinical effectiveness and cost-effectiveness of lamotrigine for people with BPD. DESIGN: A two-arm, double-blind, placebo-controlled individually randomised trial of lamotrigine versus placebo. ...We excluded people with coexisting psychos …
OBJECTIVE: To examine the clinical effectiveness and cost-effectiveness of lamotrigine for people with BPD. DESIGN: A two-arm, double …
Lamotrigine-induced pancytopenia in bipolar disorder.
Chang CF, Chung KH. Chang CF, et al. J Formos Med Assoc. 2018 Dec;117(12):1128-1129. doi: 10.1016/j.jfma.2018.07.004. Epub 2018 Jul 20. J Formos Med Assoc. 2018. PMID: 30033033 Free article. No abstract available.
Acute lamotrigine overdose: a systematic review of published adult and pediatric cases.
Alyahya B, Friesen M, Nauche B, Laliberté M. Alyahya B, et al. Clin Toxicol (Phila). 2018 Feb;56(2):81-89. doi: 10.1080/15563650.2017.1370096. Epub 2017 Sep 1. Clin Toxicol (Phila). 2018. PMID: 28862044
CONTEXT: Lamotrigine is a broad-spectrum anticonvulsant commonly used to treat seizure and bipolar mood disorders. Evidence from case series and retrospective studies indicate that lamotrigine overdose is usually benign. ...Articles were eligible if they desc …
CONTEXT: Lamotrigine is a broad-spectrum anticonvulsant commonly used to treat seizure and bipolar mood disorders. Evidence fr …
1,030 results
Jump to page
Feedback